Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions reflect a nuanced view, with users highlighting safety findings and potential applications, such as mentions of the NAD tests used and future Phase 2 trials. Phrases like 'looking forward' and 'positive safety study' demonstrate cautious optimism and engagement with ongoing research, but the mixed comments suggest a balanced perception of impact.
The discussions show mixed feelings; some posts acknowledge safety and potential, while others highlight limited efficacy, leading to a neutral overall stance.
Participants demonstrate moderate curiosity, especially with mentions of safety and future research phases, but some posts focus on technical aspects or express cautious optimism.
Posts engage with the study details, mentioning specific methods like NAD testing and referencing follow-up plans, indicating a moderate level of interest and discussion depth.
The overall influence appears moderate; while the study is seen as a step forward, there is recognition that results are preliminary and more research is needed.
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment https://t.co/jpZv9FZZ1N https://t.co/7SDpCq4r5H
@PeterAttiaMD For example, he uses the Jinfiniti intracellular NAD test, and uses nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) to bring those levels up. This supplementation alone can lower the rate of aging on biological clocks: https://t.co/0q32qebixn
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment Miranda Orr, @BeckyBPowers https://t.co/jpZv9FZrcf https://t.co/RDb7xVRZzR
NEW: A randomized placebo-controlled trial of NR in older adults with mild cognitive impairment https://t.co/W3CMXDlHNk A positive safety study. Looking forward to Phase 2
Orr, M.E., Kotkowski, E., Ramirez, P. et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience (2023). https://t.co/w7o1hoJZSN
RT @ChrisMasterjohn: @PeterAttiaMD For example, he uses the Jinfiniti intracellular NAD test, and uses nicotinamide riboside (NR) or nicoti…
Nicotinamide riboside (NR) boosts blood NAD+ levels, potentially enhancing brain function, which was tested in a pilot study on older adults with mild cognitive impairment to assess its safety and effectiveness. The…
Join Dr Jace and Dr Addy as they explore the science and benefits of NAD therapy, covering cardiovascular health, muscular endurance, cognitive function, anti-aging, and metabolic health, with practical protocols and…
RT @ChrisMasterjohn: @PeterAttiaMD For example, he uses the Jinfiniti intracellular NAD test, and uses nicotinamide riboside (NR) or nicoti…
RT @ChrisMasterjohn: @PeterAttiaMD For example, he uses the Jinfiniti intracellular NAD test, and uses nicotinamide riboside (NR) or nicoti…
@PeterAttiaMD For example, he uses the Jinfiniti intracellular NAD test, and uses nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) to bring those levels up. This supplementation alone can lower the rate of aging on biological clocks: https://t.co/0q32qebixn
RT @agingdoc1: A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment Miranda Orr,…
RT @agingdoc1: A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment https://t.co/…
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment Miranda Orr, @BeckyBPowers https://t.co/jpZv9FZrcf https://t.co/RDb7xVRZzR
NEW: A randomized placebo-controlled trial of NR in older adults with mild cognitive impairment https://t.co/W3CMXDlHNk A positive safety study. Looking forward to Phase 2
RT @agingdoc1: A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment https://t.co/…
Orr, M.E., Kotkowski, E., Ramirez, P. et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience (2023). https://t.co/w7o1hoJZSN
RT @agingdoc1: A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment https://t.co/…
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment https://t.co/jpZv9FZZ1N https://t.co/7SDpCq4r5H
DOI: 10.1007/s11357-023-00999-9. DOI: 10.1016/j.mad.2010.02.005. DOI: 10.1016/j.exger.2010.07.001 #longevidade #nutricaodeprecisao ...
DOI: 10.1007/s11357-023-00999-9. DOI: 10.1016/j.mad.2010.02.005. DOI: 10.1016/j.exger.2010.07.001 #longevidade #nutricaodeprecisao ...
... 10.1007/s11357-023-00999-9 DOI: 10.1016/j.mad.2010.02.005 DOI: 10.1016/j.exger.2010.07.001 #longevidade #nutricaodeprecisao #suplementos ...
DOI: 10.1007/s11357-023-00999-9. DOI: 10.1016/j.mad.2010.02.005. DOI: 10.1016/j.exger.2010.07.001 #longevidade #nutricaodeprecisao ...
https://doi.org/10.1007/s11357-023-00999-9. Szarvas, Z., Reyff, Z. A., Peterfi, A., Pinto, C. B., Owens, C. D., Kaposzta, Z., Mukli, P ...
https://doi.org/10.1007/s11357-023-00999-9. Szarvas, Z., Reyff, Z. A., Peterfi, A., Pinto, C. B., Owens, C. D., Kaposzta, Z., Mukli, P ...
DOI: 10.1007/s11357-023-00999-9. DOI: 10.1016/j.mad.2010.02.005. DOI: 10.1016/j.exger.2010.07.001 #longevidade #nutricaodeprecisao ...
A
CM
RC
JM
SB
ES
DP
A
M
F